This week's set of innovators to know are making waves in industries across Houston. Courtesy photos

In this Monday roundup of Houston innovators, we traverse into the restaurant, health care, and higher education industries with a startup founder focused on using technology to improve the dining experience, a self-starter in health care, and a leader on the Rice University campus with a new office for his growing staff.

Brad Burke, managing director of the Rice Alliance for Technology and Entrepreneurship

Photo via alliance.rice.edu

The Rice Alliance for Technology and Entrepreneurship has moved into its new Gensler-designed, 3,000-square-foot Bill and Stephanie Sick Suite that is expected to be a game changer for the program.

"The Rice Alliance meets frequently with venture capitalists, entrepreneurs, students, mentors, and other members of the Houston entrepreneurial ecosystem," says Brad Burke, who leads the innovation arm of Rice University. "The new space is on the first floor of the Jones School and is much more accessible and visible to our guests and visitors." Click here to read more and see photos of the space.

Roberta Schwartz, executive vice president and chief innovation officer at Houston Methodist

Courtesy of Houston Methodist

Roberta Schwartz is an innovator by nature. On last week's episode of the Houston Innovators Podcast, she shared her story of overcoming breast cancer as a young woman. Seeking a support system and camaraderie, she co-founded the Young Survival Coalition.

"I was 27 when I was unexpectedly diagnosed with breast cancer — I have no family history, no cancer in the family. It certainly was a shock to my system," Schwartz says on this week's episode of the Houston Innovators Podcast. "Once I was diagnosed, and through some of the original surgery and care I had to do, I knew that I wanted to reach out and find a larger community of young women."

Now, she's leading Houston Methodist's Center for Innovation, another entity she saw a need for, then created. Click here to read the story and stream the podcast episode.

Ken Bridge, founder of Roovy Technologies

Photo courtesy of Roovy

People use their smartphones for everything these days. So, Houston restaurateur Ken Bridge thought, why couldn't they use them to optimize their dining experience? Bridge created Roovy Technologies, and the app uses point-of-sale technology to put the power of ordering, paying, and communicating with the kitchen and bar, right into the hands of customers.

"Roovy is a platform that allows the user to order and pay entirely from their phone," says Bridge. "We will soon be the first company to have all three categories of this type of app: dine-in, take out and delivery." Click here to read more about Roovy.

Houston-based Roovy Technologies has created a mobile app where people can control their dining experience completely from their phones. Photo via roovy.io

Growing Houston startup is digitizing the dining experience

Digital dinner

Imagine going into a popular restaurant, sitting down at an open table and controlling the entire dining experience from a smartphone.

That's food, drinks, and even dessert all ordered and paid for on a phone.

Prolific Houston-area restaurateur Ken Bridge had the vision to converge dining with technology by creating a digital solution to combat chronic wait times in restaurants.

That vision became the Roovy Technologies mobile app, a platform designed to create the ultimate convenience for gastronauts everywhere.

"Roovy was birthed out of frustration," says Bridge, the serial entrepreneur behind the Delicious Concepts restaurant group. "Years ago, we would typically have lines out the door, so I thought to myself, that with technology, there should be a way for a guest to come in and manage their experience entirely from their phone.

"I felt like guests could go in, get sat at a table and order their food from their phone and pay from their phone and call it a day. That's how the idea of Roovy was conceived."

Three years ago, after putting mock pages together, Bridge started attending South by Southwest Interactive in Austin for research and inspiration. That led to commissioning a local boutique development agency in Houston to build out Roovy's Minimum Viable Product or road map before creating a fully functional platform.

"Roovy is a platform that allows the user to order and pay entirely from their phone," says Bridge. "We will soon be the first company to have all three categories of this type of app: dine-in, take out and delivery."

Bridge deployed Roovy in his Japanese concept restaurant, Blackbird Izakaya, at 1221 W. 11th St. in the Heights several months ago to test out the app before rolling it out to several other restaurants.

"It's a work in progress like everything else," says Bridge, who hopes for Roovy to be deployed in 20 restaurants very soon, then 40. "Everyday we're going to have issues that we need to resolve. But for now, we'll build it, we'll test it, we'll learn and we'll continue to go back and work out the kinks and keep pushing forward from there."

Convenience — on both sides of the transaction

For users, the value proposition is to be able to order and pay from their phone.

"Even a really good server can be impeding at the same time, over-qualifying or checking too much on a table that it becomes a distraction," says Bridge. "With Roovy, when the user is ready to order they can. It's convenience-based technology."

For operators, it streamlines the entire process, up to and including payment.

"We built this as a native solution, so restaurants can technically operate their entire restaurant on one single iPad, while cutting out all hardware," says Bridge.

The restaurant's menu is fully interactive and constantly updated in the app.

When a user places an order, they can add notes to alert the kitchen or bar with their allergies or substitutions and the kitchen or bar receives the notice on the Kitchen Display Side.

That order is then colored and timed, depending on the restaurant's flow and the user then receives a page when the order is ready.

"When restaurant's not packed, they can prepare orders in four minutes, but when packed, it may take eight minutes," says Bridge. "So through the machine learning, they can input a flow time, but then the system intuitively will become more and more intelligent based on the number of tickets and how frequently the operator is stocking and selling a particular item."

Bridge funded Roovy with his own money, so running the cloud-based platform in his own restaurants provided another distinct advantage for his startup's bottom line. And, with operators running the Roovy platform, it has officially entered post-revenue valuation. Roovy's revenue, like other payments facilitators, comes from its restaurant clients.

With the method of payment tied into the app, users pay from their phone and Roovy processes that payment transaction between the user, operator and bank tied to that payment method for a processing fee, much like a point-of-sale provider would with traditional POS devices.

Increasing opportunities for sales

What separates Roovy from other processors, though, is more than just the disruption of bulky hardware, printers and other equipment that can be very expensive for the operator.

It's the ability to maximize sales through convenience.

Case in point: in a busy restaurant, customers who have finished their meal, but possibly have cravings for another drink or a dessert might choose to eschew the urge based on the availability of their wait staff or the line at the bar.

But with Roovy, they could simply add the additional food item or drink to their cart, and have it at their table in no time.

"A lot of restaurants are not taking advantage of opportunities to maximize their sales," says Bridge. "If the per person average for a particular restaurant is $20, the likelihood that there are customers that want one more beer but don't want to go through the motions of ordering it based on service not being around is high. They're going to just leave and the restaurant just missed out on a potential $6.

"That would have been a 30 percent increase in sales," Bridge continues. "So, because of Roovy's ease of use, restaurants can increase their per person revenue and we guarantee an increase of 19 or 20 percent for operators that use our platform."

An additional revenue stream for Roovy centers on its pinpointed marketing campaigns designed to push promotions to its users based on user data and analytics.

"We can help operators run promotions for our users that can be very specific to the demographic of their choice," says Bridge. "They can be very direct and specific push notifications that go out to users based on location, vicinity or proximity, for example. We could also push notifications to a restaurant's repeat customers."

More features to come

For users that want take out, Roovy will be working with predictive arrival technology to estimate better execution times for orders so that they will be as fresh as possible for customer pickup.

Roovy will also be adding "Roovy Coin," a loyalty and rewards programs, as well as a social component for those users that like to share their experience with their friends.

"Beyond this super unique emerging technology, we are building heavily on the sociability aspects of it," says Bridge. "For example, users will be able to check in with friends, plan potential meetups, share video clips with their friends and the community on the platform and be able to review restaurants.

"I kid about this all the time, but most of us remember two things: the first kiss we had and the first time we used Uber. We'll never forget that. Our goal is to come in with that same kind of impact and convince users and operators that Roovy is not just a great technology, it's the inevitable technology that will be adopted on mass levels."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.